The agency says mobile traffic has more than doubled over the past 12 months.
Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.
The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.
The months-old app seeks to become an all-in-one HCP tool and work on a 3.0 version is already in place.
A CME activity was associated with increased testing that could head off neuropathy in patients with type 2 diabetes.
CMI/Compas says mobile-ad recall is low but growing, and that smartphones rule professional mobile use.
Responsive-design PracticeUpdate absorbs OncologyStat to become a more wide-ranging resource of curated content that spans the medical field, not just the Dutch publisher's media.
Pfizer launched ten mobile sites in four months last year by tackling tough problems early and building a template for all its brands.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.